Medindia

X

Efficacy can be Improved by Engineered Anti-Toxin Antibodies

by Kathy Jones on  January 12, 2014 at 6:11 PM Research News   - G J E 4
While the role of antibodies is quite clear in the sphere of immunology, researchers are still working on explaining the various mechanisms of action involved here.
 Efficacy can be Improved by Engineered Anti-Toxin Antibodies
Efficacy can be Improved by Engineered Anti-Toxin Antibodies
Advertisement

The effectiveness of toxin-neutralizing antibodies is considered to be mediated through the interaction of the variable region of the antibody and the toxin; however, recent studies suggest that the constant region (Fc) of antibodies also influence efficacy.In this issue of the Journal of Clinical Investigation, Jeffrey Ravetch and colleagues at The Rockefeller University demonstrate that engineering the Fc domain of anti-toxin antibodies increases toxin neutralization activity through enhancing the interaction between toxin-targeting antibodies and the Fc receptor on immune cells. The authors found that mice expressing humanized FcR were better protected from anthrax toxin when given engineered anti-anthrax toxin antibodies. This study suggests that engineering the Fc domains of antibodies can be used as a strategy to enhance antibody efficacy.

Advertisement


Source: Eurekalert
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All